Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $17.00 to $14.00. They now have a "buy" rating on the s...
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Cowen Inc. to $8.00.MarketBeat
- PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations SummitPR Newswire
- Pacific Biosciences of California (PACB) Q2 2022 Earnings Call Transcript [The Motley Fool]The Motley Fool
- Pacific Biosciences of California, Inc's (PACB) CEO Christian Henry on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- PacBio Announces Second Quarter 2022 Financial ResultsPR Newswire
PACB
Earnings
- 8/3/22 - In-Line
PACB
Sec Filings
- 8/8/22 - Form 10-Q
- 8/3/22 - Form 8-K
- 6/30/22 - Form 8-K
- PACB's page on the SEC website